Trial intelligence / Profile preview

Low-Volume Bisacodyl/PEG-CS vs Standard PEG for Colonoscopy

NCT01685853Phase 3Completed

Sponsor
European Institute of Oncology
Start
Apr 2011
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bisacodyl, macrogol in colonoscopy, sponsored by European Institute of Oncology. Started Apr 2011; status: completed.

02

Drugs

bisacodylmacrogol
03

Conditions

colonoscopy

Beyond the preview

Go deeper on NCT01685853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01685853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call